Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Pelvic x-rays can be conducted on a trauma trolley or conventional table bucky. The aim of this study was to compare the positional challenges and reject rate between pelvic x-ray images taken on a trauma trolley and a table bucky during a 12-month period in an Australian public metropolitan hospital's emergency department and to determine the accuracy rate of anatomical inclusion via a qualitative assessment of pelvic x-rays using a modified Visual Grading Scale (VGS).

Methods: A retrospective clinical audit of pelvic x-ray image reject rates over a 12-month period was conducted for an emergency department at an Australian hospital. Reject rate and anatomical cut-off were compared between images taken on a trauma trolley and a table bucky using independent samples t-test.

Results: A total of 1847 patients who underwent pelvic x-ray examinations were included in the study. The mean reject rate and the first exposure accuracy of pelvis x-rays taken on a trauma trolley were 35.5% and 56.7% respectively, while the mean reject rate and the first exposure accuracy for images taken on a table bucky were 18.8% and 81.8%, respectively (p < 0.01). The superior and lateral anatomy cut-off were the major causes of image rejection for both techniques.

Conclusions: Pelvic x-rays taken on a trauma trolley had a significantly higher reject rate and lower first exposure accuracy compared with those taken on an x-ray table. Future studies could involve implementing strategies to reduce the reject rate of pelvic x-rays taken on trauma trolleys.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmrs.70004DOI Listing

Publication Analysis

Top Keywords

trauma trolley
20
table bucky
20
pelvic x-ray
16
reject rate
16
trolley table
12
positional challenges
8
reject rates
8
pelvic x-rays
8
images trauma
8
12-month period
8

Similar Publications

Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety.

Health Data Sci

September 2025

Renal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China; Research Units of D

Recently, several cutting-edge experimental studies have directed chimeric antigen receptor (CAR)-T therapies toward specific renal diseases, revealing substantial renal benefits. Prior to widespread implementation of these animal experiments and potentially clinical trials, it is crucial to assess the renal safety of CAR-T therapies using real-world safety evidence. Our focus was on utilizing 4 algorithms, including disproportionality analysis, based on the US Food and Drug Administration Adverse Event Reporting System database, to filter positive signals of acute and chronic renal injury associated with 6 CAR-T therapies.

View Article and Find Full Text PDF

Large-scale combat operations (LSCO) will challenge the current U.S. military trauma system with high casualty volumes, prolonged evacuation timelines, and degraded logistics.

View Article and Find Full Text PDF

Bridging the gaps in surgical education for the expeditionary surgeon: A position paper from the American Association for the Surgery of Trauma Military Liaison Committee.

J Trauma Acute Care Surg

August 2025

From the Department of Surgery (E.W.B.), University of Alabama Birmingham, Birmingham, Alabama; University of South Florida (J.H.A.), Tampa, Florida; University of Texas Southwestern (D.B.), Dallas, Texas; Loyola University (F.L.), Chicago, Illinois; University of Texas San Antonio Health Science Ce

Background: Military surgical training ensures that surgeons are prepared to care for combat casualties, service members, and beneficiaries. As the wars of the first two decades of this century have concluded, proper preparation for the next generation of expeditionary surgeons has gained renewed attention. This spotlight, however, has revealed significant challenges that hinder the readiness of both resident and staff surgeons.

View Article and Find Full Text PDF

Nanomaterial-induced immunogenic cell death (ICD) represents a transformative approach to overcoming limitations of conventional cancer immunotherapies. Unlike traditional methods hindered by systemic toxicity and inadequate targeting, nanomaterials precisely deliver therapeutic agents and effectively modulate tumor microenvironmental factors, including hypoxia, acidity, and redox imbalance. By triggering ICD through mechanisms such as reactive oxygen species generation, tumor acidity neutralization, and hypoxia alleviation, nanomaterials facilitate potent anti-tumor immune responses, enhance dendritic cell activation, and promote cytotoxic T lymphocyte recruitment.

View Article and Find Full Text PDF